Advertisement
Screener

ENTRADA THERAPEUTICS, INC. (TRDA) Employee Count

ENTRADA THERAPEUTICS, INC. Employee Count

The employee counts ENTRADA THERAPEUTICS, INC. states in its annual reports on SEC EDGAR, each as filed.

  • 2025-12-31: Employees (as filed) 152; Filing 2026-02-26; Lease expense per employee $99,013.16.
  • 2024-12-31: Employees (as filed) 183; Filing 2025-02-27; Lease expense per employee $84,890.71.
  • 2023-12-31: Employees (as filed) 159; Filing 2024-03-13; Lease expense per employee $103,113.21.
  • 2022-12-31: Employees (as filed) 130; Filing 2023-03-06; Lease expense per employee $67,492.31.
Available history
2021-12-31 to 2025-12-31

Historical Employee Count

DateEmployees (as filed)FilingLease expense per employee
2025-12-31152
full-time
2026-02-26$99,013.16
total lease cost
2024-12-31183
full-time
2025-02-27$84,890.71
total lease cost
2023-12-31159
full-time
2024-03-13$103,113.21
total lease cost
2022-12-31130
full-time
2023-03-06$67,492.31
total lease cost
2021-12-31114
full-time
2022-03-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
MACROGENICS INC (MGNX)United States$0.242B-20.11
Pyxis Oncology, Inc. (PYXS)United States$0.244B
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
Lyell Immunopharma, Inc. (LYEL)United States$0.248B-1.32
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
Akebia Therapeutics, Inc. (AKBA)United States$0.255B-10.35
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55